ABOUT THIS EVENT

Kinnate Biopharma Inc. (Nasdaq: KNTE), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, visits the Nasdaq MarketSite in Times Square to celebrate their one-year anniversary of trading on the exchange.

In honor of the occasion, Nima Farzan, CEO, rings the Closing Bell.